Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q1 2023 · 10-Q
Revenue$6.09M$6.09M−34.7% vs Q1 2022 Net Income-$3.96M-$3.96MN/M vs Q1 2022 EPS Diluted-$0.08-$0.08N/M vs Q1 2022 Gross Profit$3,567,766−28.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flow-$2,064,357N/M Free Cash Flowderived-$2,241,727N/M Margins · derivedGross margin58.6%+5.1 pt vs Q1 2022
Operating margin-66.5%+203.3 pt vs Q1 2022
Net margin-65.0%+140.5 pt vs Q1 2022
ended Dec 31, 2022 · filed Feb 13, 2023 · 44 d after period end